Novartis AG (NVS) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Core Income ... [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Core Operating Income: Down 14%, impacted by sales decline and increased R&D investments. Kisqali Growth: 55% growth in Q1, strong performance in early and metastatic breast cancer. Kesimpta Growth: 26% growth, with 21% TRx growth in the US. Pluvicto Growth: US sales grew 76%, with 48% growth outside the US. Leqvio Growth: 31% growth in the US, 106% growth outside the US. Scemblix Growth: 79% growth, strong performance in the US and ex-US markets. Cosentyx Sales: Broadly stable, with estimated 2% global sales growth. Free Cash Flow: Broadly in line with previous year Q1, supported by favorable working capital movement. Dividend and Share Buyback: $9.1 billion paid in dividends, $6.1 billion remaining in share buyback program. Full Year 2026 Guidance: Low single-digit sales growth and low single-digit decline in core operating income expected. Exchange Rate Impact: Expected positive 2% impact on full year sales and positive 1% on core operating income. Warning! G
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis finalizes US manufacturing and R&D expansion plan with seventh new facilityGlobeNewswire
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [MSNBC.com]MSNBC.com
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [CNBC]CNBC
- Novartis Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/28/26 - Miss
NVS
Sec Filings
- 4/28/26 - Form 6-K
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- NVS's page on the SEC website